Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies

v2.4.0.8
Commitments and Contingencies
 9 Months Ended
Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Commitments and Contingencies
Obligations
Future obligations and commitments, which are comprised of future minimum lease payments, inventory purchase obligations, and contingent consideration increased $1.0 million in the nine months ended December 31, 2013, to $20.0 million, from $19.0 million at March 31, 2013. The Kentrox segment accounted for $0.8 million of the increase. The Westell segment increase resulted primarily from cell site and DAS product purchase obligations.
Purchase obligations consist of inventory that arises in the normal course of business operations. Future obligations and commitments as of December 31, 2013, consisted of the following:
 
Payments due within
(in thousands)
Year 1
 
Year 2
 
Year 3
 
Year 4
 
Year 5
 
Thereafter
 
Total
Purchase obligations
$
9,297

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
9,297

Future minimum operating lease
 payments
2,774

 
2,131

 
2,152

 
1,086

 
—

 
—

 
8,143

Contingent consideration
1,793

 
785

 
—

 
—

 
—

 
—

 
2,578

Future obligations and
commitments
$
13,864

 
$
2,916

 
$
2,152

 
$
1,086

 
$
—

 
$
—

 
$
20,018


Litigation and Contingency Reserves
The Company and its subsidiaries are involved in various assertions, claims, proceedings and requests for indemnification concerning intellectual property, including patent infringement suits involving technologies that may be incorporated in the Company’s products, which are being handled and defended in the ordinary course of business.  These matters are in various stages of investigation and litigation, and they are being vigorously defended.  Although the Company does not expect that the outcome in any of these matters, individually or collectively, will have a material adverse effect on its financial condition or results of operations, litigation is inherently unpredictable.  Therefore, judgments could be rendered, or settlements entered, that could adversely affect the Company’s operating results or cash flows in a particular period. The Company routinely assesses all of its litigation and threatened litigation as to the probability of ultimately incurring a liability, and it records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.
As of December 31, 2013, and March 31, 2013, the Company had total contingency reserves of $0.7 million and $1.7 million, respectively, related to certain intellectual property and indemnification claims. The contingency reserves relate to the discontinued operations of ConferencePlus and are classified as Accrued expenses on the Condensed Consolidated Balance Sheets. In the nine months ended December 31, 2013, the Company paid $1.1 million relating to an indemnification claim.
Additionally, the Company has a contingent cash consideration payable related to the ANTONE acquisition.  The ANTONE contingent consideration becomes payable based upon the profitability of the acquired products for post-closing periods through June 30, 2016, and is offset by working capital adjustments and other indemnification claims. The maximum earn-out that could be paid before offsets is $3.5 million. As of December 31, 2013, and March 31, 2013, the fair value of the contingent consideration liability after offsetting a working capital adjustment and an indemnification claim for warranty obligations was $2.6 million and $2.3 million, respectively (see Notes 7 and 12).